Andrew Radin (@andrew_radin) 's Twitter Profile
Andrew Radin

@andrew_radin

Scientist. Builder. Philanthropist. Entrepreneur.
CEO, Aria Pharmaceuticals @ariapharma

ID: 85820486

linkhttp://www.linkedin.com/in/andrewradin calendar_today28-10-2009 13:45:50

366 Tweet

477 Followers

159 Following

Andrew Radin (@andrew_radin) 's Twitter Profile Photo

Indeed, what we do is very different than other #AI companies in #drugdiscovery. @BioSpace covered the details in their latest article on Aria Pharmaceuticals

Andrew Radin (@andrew_radin) 's Twitter Profile Photo

If you are like me and think #AI in #drugdiscovery might be a wee bit over-hyped, check out my latest op-ed published in EBR.

Andrew Radin (@andrew_radin) 's Twitter Profile Photo

Here is an excellent article on progression in AI in #drugdiscovery with quotes from me and my friends at excentia, AstraZeneca and LifeMine Therapeutics fiercebiotech.com/medtech/fierce…

Aria Pharmaceuticals (@ariapharma) 's Twitter Profile Photo

CEO Andrew Radin joined the Fierce Biotech NextGen Summit to discuss the strides made in integrating AI in healthcare and drug discovery & development. Read some of the highlights here: ariapharmaceuticals.com/fierce-next-ge…

Andrew Radin (@andrew_radin) 's Twitter Profile Photo

It's my pleasure to announce our recent patents in three disease areas as we prepare to go to the clinic. All made possible by the stellar team at Aria Pharmaceuticals

Andrew Radin (@andrew_radin) 's Twitter Profile Photo

If you haven’t yet registered for the FierceBiotech Summit next week, feel free to use my discount code SPKVIP. I’m looking forward to joining our panel of experts on AI and drug discovery and sharing my perspectives.

If you haven’t yet registered for the <a href="/FierceBiotech/">FierceBiotech</a>  Summit next week, feel free to use my discount code SPKVIP. I’m looking forward to joining our panel of experts on AI and drug discovery and sharing my perspectives.
Aria Pharmaceuticals (@ariapharma) 's Twitter Profile Photo

Join Aria SVP of Nonclinical R&D and Chemistry Anjali Pandey at Discovery on Target 2022 this week where she will be presenting the latest findings from our #NASH and #IPF programs! Register here: discoveryontarget.com/nash-fibrosis

Andrew Radin (@andrew_radin) 's Twitter Profile Photo

After listening to ye and Balaji back to back on the Lex Fridman podcast I am beginning to wonder if exceptional coherence and exceptional incoherence sound exactly the same.